Omega Healthcare Investors, Inc. reported strong fourth quarter 2024 results with net income of $116 million and Adjusted FFO of $214 million. The company completed $340 million in new investments during the quarter and issued $438 million in equity, while also providing 2025 Adjusted FFO guidance.
Net income for Q4 2024 increased to $116 million, up from $57 million in Q4 2023.
Adjusted FFO for Q4 2024 was $214 million, or $0.74 per common share, compared to $173 million, or $0.68 per common share, for Q4 2023.
The company completed approximately $340 million in new investments in Q4 2024, consisting of $179 million in real estate acquisitions and $162 million in real estate loans.
Omega issued 11 million common shares in Q4 for gross proceeds of $438 million.
The Company expects its 2025 Adjusted FFO to be between $2.90 and $2.98 per diluted share, based on several assumptions including annual impact of acquisitions, asset sales, debt repayments, and no material changes in market interest rates.
Analyze how earnings announcements historically affect stock price performance